Aromolaran KA, Goldstein PA (2017) Ion channels and neuronal hyperexcitability in chemotherapy-induced peripheral neuropathy; cause and effect? Mol Pain 13:1744806917714693. https://doi.org/10.1177/1744806917714693

Article  CAS  PubMed  PubMed Central  Google Scholar 

Azam L, McIntosh JM (2012) Molecular basis for the differential sensitivity of rat and human α9α10 nAChRs to α-conotoxin RgIA. J Neurochem 122(6):1137–1144. https://doi.org/10.1111/j.1471-4159.2012.07867.x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bae EH, Greenwald MK, Schwartz AG (2021) Chemotherapy-induced peripheral neuropathy: mechanisms and therapeutic avenues. Neurotherapeutics 18(4):2384–2396. https://doi.org/10.1007/s13311-021-01142-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bjornard KL, Gilchrist LS, Inaba H, Diouf B, Hockenberry MJ, Kadan-Lottick NS, Bowers DC, Dolan ME, Ullrich NJ, Evans WE, Ness KK (2018) Peripheral neuropathy in children and adolescents treated for cancer. Lancet Child Adolesc Health 2(10):744–754. https://doi.org/10.1016/s2352-4642(18)30236-0

Article  PubMed  PubMed Central  Google Scholar 

Brett Whalen L, Zachary Wright W, Kundur P, Angadi S, Modesitt SC (2022) Beneficial effects of exercise on chemotherapy-induced peripheral neuropathy and sleep disturbance: a review of literature and proposed mechanisms. Gynecol Oncol Rep 39:100927. https://doi.org/10.1016/j.gore.2022.100927

Article  CAS  PubMed  PubMed Central  Google Scholar 

Canta A, Pozzi E, Carozzi VA (2015) Mitochondrial dysfunction in chemotherapy-induced peripheral neuropathy (CIPN). Toxics 3(2):198–223. https://doi.org/10.3390/toxics3020198

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng K, Martin LF, Slepian MJ, Patwardhan AM, Ibrahim MM (2021) Mechanisms and pathways of pain photobiomodulation: a narrative review. J Pain 22(7):763–777. https://doi.org/10.1016/j.jpain.2021.02.005

Article  PubMed  PubMed Central  Google Scholar 

Choudhary S, Kaur R, Waziri A, Garg A, Kadian R, Alam MS (2023) N-type calcium channel blockers: a new approach towards the treatment of chronic neuropathic pain. Explor Med 4(1):85–106. https://doi.org/10.37349/emed.2023.00126

Article  CAS  Google Scholar 

Christensen SB, Hone AJ, Roux I, Kniazeff J, Pin JP, Upert G, Servent D, Glowatzki E, McIntosh JM (2017) RgIA4 potently blocks mouse α9α10 nAChRs and provides long lasting protection against oxaliplatin-induced cold allodynia. Front Cell Neurosci 11:219–224. https://doi.org/10.3389/fncel.2017.00219

Article  CAS  PubMed  PubMed Central  Google Scholar 

Colvin LA (2019) Chemotherapy-induced peripheral neuropathy: where are we now? Pain 160(1(Suppl 1)):S1–s10. https://doi.org/10.1097/j.pain.0000000000001540

Article  CAS  PubMed  PubMed Central  Google Scholar 

Di Cesare Mannelli L, Pacini A, Matera C, Zanardelli M, Mello T, De Amici M, Dallanoce C, Ghelardini C (2014) Involvement of α7 nAChR subtype in rat oxaliplatin-induced neuropathy: effects of selective activation. Neuropharmacology 79:37–48. https://doi.org/10.1016/j.neuropharm.2013.10.034

Article  CAS  PubMed  Google Scholar 

Dutertre S, Jin AH, Kaas Q, Jones A, Alewood PF, Lewis RJ (2013) Deep venomics reveals the mechanism for expanded peptide diversity in cone snail venom. Mol Cell Proteom 12(2):312–329. https://doi.org/10.1074/mcp.M112.021469

Article  CAS  Google Scholar 

Dyachenko IA, Palikova YA, Palikov VA, Korolkova YV, Kazakov VA, Egorova NS, Garifulina AI, Utkin YN, Tsetlin VI, Kryukova EV (2022) α-Conotoxin RgIA and oligoarginine R8 in the mice model alleviate long-term oxaliplatin induced neuropathy. Biochimie 194:127–136. https://doi.org/10.1016/j.biochi.2021.12.013

Article  CAS  PubMed  Google Scholar 

Eldridge S, Guo L, Hamre J 3rd (2020) A comparative review of Chemotherapy-Induced peripheral neuropathy in in vivo and. Vitro Models Toxicol Pathol 48(1):190–201. https://doi.org/10.1177/0192623319861937

Article  PubMed  Google Scholar 

Giraudo A, Pallavicini M, Bolchi C (2023) Small molecule ligands for α9 * and α7 nicotinic receptors: A survey and an update, respectively. Pharmacol Res 193:106801–106831. https://doi.org/10.1016/j.phrs.2023.106801

Article  CAS  PubMed  Google Scholar 

Guo M, Li Z, Deng X, Luo D, Yang J, Chen Y, Xue W (2024) ConoDL: a deep learning framework for rapid generation and prediction of conotoxins. J Comput Aided Mol Des 39(1):4–9. https://doi.org/10.1007/s10822-024-00582-0

Article  CAS  PubMed  Google Scholar 

Ho TNT, Abraham N, Lewis RJ (2020) Structure-function of neuronal nicotinic acetylcholine receptor inhibitors derived from natural toxins. Front Neurosci. https://doi.org/10.3389/fnins.2020.609005

Article  PubMed  PubMed Central  Google Scholar 

Hone AJ, McIntosh JM (2018) Nicotinic acetylcholine receptors in neuropathic and inflammatory pain. FEBS Lett 592(7):1045–1062. https://doi.org/10.1002/1873-3468.12884

Article  CAS  PubMed  Google Scholar 

Hone AJ, Servent D, McIntosh JM (2018) α9-containing nicotinic acetylcholine receptors and the modulation of pain. Br J Pharmacol 175(11):1915–1927. https://doi.org/10.1111/bph.13931

Article  CAS  PubMed  Google Scholar 

Hooijmans CR, Draper D, Ergün M, Scheffer GJ (2019) The effect of analgesics on stimulus evoked pain-like behaviour in animal models for chemotherapy induced peripheral neuropathy- a meta-analysis. Sci Rep 9(1):175–182. https://doi.org/10.1038/s41598-019-54152-8

Article  CAS  Google Scholar 

Huynh PN, Christensen SB, McIntosh JM (2022) RgIA4 prevention of acute oxaliplatin-induced cold allodynia requires α9-containing nicotinic acetylcholine receptors and CD3(+) T-cells. Cells 11(22):3561–3578. https://doi.org/10.3390/cells11223561

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huynh PN, Giuvelis D, Christensen S, Tucker KL, McIntosh JM (2019) RgIA4 accelerates recovery from paclitaxel-induced neuropathic pain in rats. Mar Drugs 18(1):12–21. https://doi.org/10.3390/md18010012

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jensen TS, Finnerup NB (2014) Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms. Lancet Neurol 13(9):924–935. https://doi.org/10.1016/s1474-4422(14)70102-4

Article  PubMed  Google Scholar 

Jimenez EC (2021) Post-translationally modified conopeptides: biological activities and pharmacological applications. Peptides 139:170525–170532. https://doi.org/10.1016/j.peptides.2021.170525

Article  CAS  PubMed  Google Scholar 

Kaas Q, Westermann JC, Craik DJ (2010) Conopeptide characterization and classifications: an analysis using conoserver. Toxicon 55(8):1491–1509. https://doi.org/10.1016/j.toxicon.2010.03.002

Article  CAS  PubMed  Google Scholar 

Kanasuwan A, Deuther-Conrad W, Chongruchiroj S, Sarasamkan J, Chotipanich C, Vajragupta O, Arunrungvichian K (2023) Selective α(3)β(4) nicotinic acetylcholine receptor ligand as a potential tracer for drug addiction. Int J Mol Sci 24(4):3614–3618. https://doi.org/10.3390/ijms24043614

Article  CAS  PubMed  PubMed Central  Google Scholar 

Keever KR, Cui K, Casteel JL, Singh S, Hoover DB, Williams DL, Pavlov VA, Yakubenko VP (2024) Cholinergic signaling via the α7 nicotinic acetylcholine receptor regulates the migration of monocyte-derived macrophages during acute inflammation. J Neuroinflamm 21(1):3–10. https://doi.org/10.1186/s12974-023-03001-7

Article  CAS